SCHEMBL572085

SCHEMBL572085

COc1cc(OC)c(C2COc3cc(O)cc(O)c3C2=O)cc1OC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.67
ODC1 P11926 1/20 0.43
CYP19A1 P11511 3/20 0.41
XDH P47989 3/20 0.41
CYP3A4 P08684 3/20 0.41
MAPT P10636 3/20 0.41
TP53 P04637 2/20 0.41
CYP1A1 P04798 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP1B1 Q16678 2/20 0.41
POLB P06746 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
PKM P14618 1/20 0.41
NPC1 O15118 1/20 0.41
CA12 O43570 1/20 0.41
KDM1A O60341 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31238344 0.82 PTPN1 (0.56) PTPN1CYP19A1XDHCYP3A4MAPT
SCHEMBL29688602 0.81 PTPN1 (0.55) PTPN1CYP19A1CYP3A4MAPTTP53
SCHEMBL1842904 0.81 PTPN1 (0.71) PTPN1CYP19A1XDHCYP3A4MAPT
Cajanol SCHEMBL571648 0.80 PTPN1 (0.53) PTPN1CYP19A1CYP3A4MAPTTP53
SCHEMBL29737519 0.78 TDP1 (0.53) PTPN1CYP19A1CYP3A4CYP1A1CYP1A2
Dihydrobiochanin A SCHEMBL30217535 0.78 ALOX12 (0.67) PTPN1CYP19A1XDHCYP3A4MAPT
SCHEMBL9993958 0.76 PTPN1 (0.50) PTPN1CYP19A1XDHMAPTPOLB
SCHEMBL21168204 0.75 PTPN1 (0.72) PTPN1ODC1CYP19A1CYP3A4MAPT
SCHEMBL12825176 0.73 ALOX12 (0.65) PTPN1CYP19A1CYP3A4MAPTTP53
SCHEMBL29412620 0.73 ALOX12 (0.65) PTPN1CYP19A1CYP3A4MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
EP-2598150-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS The Hospital For Sick Children (CA) 2013-06-05 EP disclosed
WO-2012018643-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2012-02-09 WO disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 PTPN1 3544/4885ODC1 1329/4885CYP19A1 529/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 PTPN1 3544/4885ODC1 1329/4885CYP19A1 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.